Chairman and Chief Executive Officer
at Ratio Therapeutics
Dr. Jack Hoppin is a mathematician and entrepreneur with over 20 years of experience in nuclear medicine research and business development. He holds a doctorate in applied mathematics from the University of Arizona and was an Alexander von Humboldt Fellow in Germany. Hoppin co-founded Invicro in 2008, leading its growth to a multinational organization with 350+ employees, achieving significant success before its sale to Konica Minolta in 2017. He then served as president of their Precision Medicine business unit until 2021. Hoppin has also worked with Noria Therapeutics and co-founded Ratio Therapeutics, where he serves as CEO and Chairman.
Got a Question for Jack Hoppin, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
